The a2 Milk Co Ltd (ASX: A2M) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

The a2 Milk Co Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $6.24 billion
P/E Ratio 35.28
Dividend Yield 1.80%
Shares Outstanding 724.02 million
Earnings per share 0.279
Dividend per share 0.15
Year To Date Return -8.03%
Earnings Yield 2.83%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • The a2 Milk Co Ltd (ASX: A2M)
    Latest News

    A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
    Consumer Staples & Discretionary Shares

    Why did the A2 Milk share price sink 7% in April?

    Milk was spilt in April and investors were not happy.

    Read more »

    A woman looks in anticipation at her laptop, watching eagerly.
    Economy

    Dalio says US and China 'on brink of war'. Which ASX shares could be impacted?

    A US-China war would be devastating for ASX shares and the economy.

    Read more »

    a woman holds her hands to her temples as she sits in front of a computer screen with a concerned look on her face.
    Broker Notes

    Here's what this top broker thinks of the A2 Milk share price after recent weakness

    Should you load up on this infant formula share after this week's pullback?

    Read more »

    A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
    Share Fallers

    Why A2 Milk, Mesoblast, Mineral Resources, and Synlait shares are sinking

    These ASX shares are likely to wish that the market had stayed closed for another day.

    Read more »

    A couple sits on a sofa, each clutching their heads in horror and disbelief, while looking at a laptop screen.
    Consumer Staples & Discretionary Shares

    A2 Milk share price on watch following worrying update

    Things are not going well for A2 Milk in the daigou channel right now.

    Read more »

    A man in a business suit holds a mobile phone to his ear while he drinks a large glass of milk.
    Opinions

    The A2 Milk share price has fallen 16% in around two months: Time to buy?

    Investors are souring on the infant formula business. Is this a contrarian opportunity?

    Read more »

    Green bars of top shares with a woman on top of the tallest bar
    Share Gainers

    Here are the top 10 ASX 200 shares today

    Guess which ASX 200 healthcare share posted today's biggest gain.

    Read more »

    A woman sits with a glass of milk in front of her as she puts a finger to the side of her face as though in thought while her eyes look to the side as though she is contemplating something.
    Share Market News

    Why have A2 Milk shares come off the boil again?

    What's been happening with the infant milk company lately?

    Read more »

    A man holds his head in his hands, despairing at the bad result he's reading on his computer.
    Share Fallers

    Why did the A2 Milk share price crash 12% in March?

    It wasn't a good month for owners of this infant formula share.

    Read more »

    A young man stands facing the camera and scratching his head with the other hand held upwards wondering if he should buy Whitehaven Coal shares
    Broker Notes

    Why is the A2 Milk share price underperforming on Tuesday?

    A broker downgrade is weighing on this infant formula company's shares.

    Read more »

    A man in a business suit holds a mobile phone to his ear while he drinks a large glass of milk.
    Consumer Staples & Discretionary Shares

    Should I buy A2 Milk shares at $6?

    A2 Milk reported some strong half-year results on 20 February, with management forecasting low double-digit revenue growth.

    Read more »

    Worried ASX share investor looking at laptop screen
    Share Fallers

    Why A2 Milk, Accent, Northern Star, and Select Harvests shares are dropping

    These ASX shares are under pressure on Tuesday despite the market storming higher.

    Read more »

    Frequently Asked Questions

    The a2 Milk Company Ltd paid its maiden dividend to shareholders in April 2025.

    The a2 Milk Company Ltd does not currently have a dividend reinvestment program.

    The company was founded in 2000 in New Zealand and listed on the ASX in March 2015.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    18 Sep 2025 $0.1150 0.00% Final 03 Oct 2025
    20 Mar 2025 $0.0650 0.00% Interim 04 Apr 2025

    A2M ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About The a2 Milk Co Ltd

    A2 Milk Company Ltd (ASX: A2M) is a fresh milk and infant formula company that sources, produces and supplies a2 brand milk and milk-related products in Australia and globally.

    The Company was founded in 2000 in New Zealand by scientist Dr Corran McLachlan and Howard Paterson.

    The company produces fresh cows' milk that naturally contains the A2 protein type and no A1 protein. Some research suggests the A1 protein can cause digestion issues.

    A2M Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    02 Feb 2026 $8.60 $0.13 1.53% 1,407,396 $8.41 $8.62 $8.37
    30 Jan 2026 $8.47 $0.02 0.24% 1,242,600 $8.43 $8.52 $8.32
    29 Jan 2026 $8.45 $0.11 1.32% 1,268,125 $8.33 $8.45 $8.20
    28 Jan 2026 $8.34 $-0.05 -0.60% 1,192,309 $8.38 $8.47 $8.27
    27 Jan 2026 $8.39 $0.21 2.57% 1,946,195 $8.38 $8.63 $8.29
    23 Jan 2026 $8.18 $-0.35 -4.10% 2,297,102 $8.38 $8.59 $8.18
    22 Jan 2026 $8.53 $0.44 5.44% 2,677,993 $8.12 $8.59 $8.12
    21 Jan 2026 $8.09 $-0.28 -3.35% 2,142,846 $8.35 $8.35 $8.06
    20 Jan 2026 $8.37 $0.07 0.84% 3,994,238 $8.40 $8.51 $8.00
    19 Jan 2026 $8.30 $-1.10 -11.70% 3,258,666 $9.30 $9.40 $8.01
    16 Jan 2026 $9.40 $0.00 0.00% 1,492,109 $9.31 $9.48 $9.31
    15 Jan 2026 $9.40 $0.09 0.97% 1,030,020 $9.27 $9.47 $9.27
    14 Jan 2026 $9.31 $0.11 1.20% 3,142,020 $9.23 $9.34 $9.15
    13 Jan 2026 $9.20 $0.06 0.66% 1,880,809 $9.19 $9.24 $9.13
    12 Jan 2026 $9.14 $-0.04 -0.44% 1,888,747 $9.18 $9.21 $9.11
    09 Jan 2026 $9.18 $0.02 0.22% 650,003 $9.19 $9.28 $9.17
    08 Jan 2026 $9.16 $0.09 0.99% 1,028,591 $9.01 $9.22 $9.01
    07 Jan 2026 $9.07 $0.02 0.22% 707,059 $9.02 $9.15 $9.00
    06 Jan 2026 $9.05 $-0.19 -2.06% 961,096 $9.24 $9.28 $9.05
    05 Jan 2026 $9.24 $0.06 0.65% 550,132 $9.20 $9.32 $9.17

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    08 Dec 2025 David Bortolussi Issued 324,606 $2,940,930
    Issue of securities. 1,553,008 performance rights
    26 Nov 2025 David Bortolussi Sell 245,453 $2,672,983
    On-market trade. NZD
    26 Sep 2025 Kathryn(Kate) Mitchell Buy 2,184 $20,748
    On-market trade. NZD
    24 Sep 2025 Kathryn(Kate) Mitchell Buy 816 $7,752
    On-market trade. NZD
    23 Sep 2025 Kathryn(Kate) Mitchell Buy 3,000 $28,350
    On-market trade. NZD
    15 Sep 2025 David Bortolussi Sell 242,345 $2,484,036
    On-market trade. NZD
    26 Aug 2025 David Bortolussi Buy 484,691 $4,444,616
    Conversion of securities.
    26 Aug 2025 David Bortolussi Expiry 16,489 $151,204
    As advised by the company. Lapsed, 17,13,093 Rights
    26 Aug 2025 David Bortolussi Exercise 484,691 $4,444,616
    Conversion of securities. 12,28,402 Rights
    21 Aug 2025 Kathryn(Kate) Mitchell Buy 2,500 $24,050
    On-market trade. NZD
    20 Aug 2025 Kathryn(Kate) Mitchell Buy 5,500 $51,755
    On-market trade. NZD

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr David Landt Bortolussi Chief Executive OfficerManaging Director Feb 2021
    Mr Bortolussi, prior to joining the Company, held the role of Group President, HanesBrands, and prior to that he was the CEO of Pacific Brands. In 2016, HanesBrands acquired Pacific Brands and expanded David's role to cover international innerwear operations outside of the Americas. Prior to this, David was the Chief Strategy Officer at Foster's Group and held senior consulting roles at McKinsey & Company and PwC. David's career has been focused on the consumer and retail sector in Australia and New Zealand complemented by international experience in markets and categories in China, SE Asia, EU, UK and the USA. David also has an interest in private equity and growth-phase businesses. He is a member of the advisory board of Whiteoak and supports the development of investee companies.
    Ms Philippa (Pip) Mary Greenwood Non-Executive ChairmanNon-Executive Director Jul 2019
    Ms Greenwood is currently the Chair of Westpac New Zealand and a director of Fisher & Paykel Healthcare and Westpac Banking Corporation. She was previously a director of Spark New Zealand and Vulcan Steel. Prior to becoming a full time director, Pip was a senior partner at law firm Russell McVeagh, where she spent over 10 years on the firm's Board including acting as the firm's Board Chair and interim CEO. Pip brings commercial and board experience to The a2 Milk Company Board. She is member of People Committee.
    Ms Kathryn(Kate) Mitchell Non-Executive Director Jun 2023
    Ms Mitchell has governance experience as a director of both private and public companies. She is also skilled in the areas of financial risk management, structured financing and investments. Kate is currently Chair of The New Zealand Merino Company and Link Engine Management. She is also a director of Christchurch International Airport, where she chairs the Property and Commercial Committee. Prior to moving to New Zealand in 2014, Kate's executive career spanned 20 years in investment banking in London, which included senior leadership roles in Global Markets at Deutsche Bank, Goldman Sachs and Merrill Lynch. She is also Chair of the Risk Management Committee.
    Ms Sandra Yu Non-Executive Director Mar 2022
    Ms Yu is a company director and an experienced global executive in consumer goods industries, and importantly in the IMF market in China, with a proven track record of driving business and brand transformation, leveraging opportunities for growth, and building organisational capabilities across China as well as the USA and other parts of Asia. She is currently a director of 91AAP Inc, a retail Software as a Service provider. As the former head of Mead Johnson Nutrition's Greater China business, Sandra was a member of the Mead Johnson Nutrition's Global leadership team. Prior to that, Sandra held other senior executive roles at Mead Johnson Nutrition, including as the Global Marketing Vice President, responsible for transition to new digital media and e-commerce channels globally. Sandra was also appointed as the non-executive chairwoman to lead RB China Advisory Board after the merger between Reckitt Benckiser and Mead Johnson Nutrition in 2017. Prior to joining Mead Johnson, Sandra held executive positions at Unilever, where she worked across Asia for 13 years. Sandra is the Chair of the People Committee and member of Risk Management Committee.
    Mr Grant Andrew Dempsey Non-Executive Director Sep 2025
    Mr Dempsey brings financial, strategic and commercial experience to the Board through his career in investment banking and CFO roles held at ASX50 listed companies. Grant commenced his career as an auditor before spending time in business development at Bank of Melbourne and General Electric. Grant then gained experience in investment banking, initially at UBS and Citi, then at JP Morgan for 10 years, including as its Head of Banking. Following this, Grant held CFO roles at Alumina, a bauxite and alumina mining business, and TPG Telecom. Grant retired as an executive last year and is now a professional director. He has been a director of Industry Funds Management (IFM) Investors since 2018 and chairs its Board investment committee. More recently, he has been appointed as the Chair of Housing Hub, and a director and chair of the audit and risk committee of Sims Metals and Megaport, both of which are ASX listed companies. Grant is based in Australia.
    He is a member of Risk Management Committee.
    Mr Antonio (Tonet) Rivera Non-Executive Director Nov 2024
    Mr Rivera has over 35 years of supply chain experience, including 17 years of international leadership experience. Tonet worked for Mead Johnson Nutrition from 2002 to 2017, culminating in four years leading the global supply chain of the multinational nutrition company in the role of Senior Vice President, Global Supply Chain. In that role Tonet had responsibility for all supply chain operations globally, including manufacturing, engineering, procurement, supply planning and physical distribution. Prior to that, he served as Vice President, Supply Chain - Asia and Europe for more than a decade, with responsibility for Supply Chain operations in Europe and Asia, including owned manufacturing locations and third-party manufacturers. Since retiring from executive roles in 2017, when Mead Johnson Nutrition was acquired by Reckitt Benckiser Group plc, Tonet has worked as a supply chain consultant. He is member of Risk Management Committee.
    Mr Lain Jager Non-Executive Director Dec 2024
    Mr Jager brings international agribusiness leadership experience to the Board through his former role as CEO of Zespri International. Zespri is the marketer of kiwifruit, distributed in more than 50 countries with revenue of NZ$4.2 billion and operating profit of NZ$230 million in FY24. Lain's nine years as CEO of Zespri International from 2008 to 2017 included the development of a global growth strategy, and increases in revenue and profitability. Since stepping down from Zespri in 2017, Lain has focused on private business interests including personal investments in a range of entrepreneurial, technology and agriculture related businesses. He is member of People Committee.
    Mr Jaron McVicar Company SecretaryGeneral Counsel Nov 2016
    -
    Xiao Li Chief Executive Officer Greater China
    -
    David Muscat Chief Financial Officer
    -
    Edith Bailey Chief Marketing Officer
    -
    Amanda Hart Chief People and Culture Officer
    -
    Chopin Zhang Chief Supply Chain Officer
    -
    Jaron McVicar Company SecretaryGeneral Counsel
    -
    Eleanor Khor Managing Director ANZ and Strategy
    -
    Yohan Senaratne Managing Director International
    -
    Kevin Bush Managing Director USA
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 169,027,427 23.35%
    Citicorp Nominees Pty Limited 88,042,263 12.16%
    J P Morgan Nominees Australia Pty Limited 87,912,349 12.14%
    BNP Paribas Nominees NZ Limited Bpss40 39,982,769 5.52%
    Accident Compensation Corporation 19,325,269 2.67%
    TEA Custodians Limited 18,622,668 2.57%
    HSBC Nominees (New Zealand) Limited 17,837,054 2.46%
    New Zealand Superannuation Fund Nominees Limited 13,448,326 1.86%
    National Nominees Limited 12,571,092 1.74%
    New Zealand Depository Nominee 11,915,919 1.65%
    Citibank Nominees (NZ) Ltd 10,629,794 1.47%
    BNP Paribas Noms Pty Ltd 10,287,073 1.42%
    BNP Paribas Nominees Pty Ltd 9,139,860 1.26%
    Public Trust 8,352,117 1.15%
    Premier Nominees Limited 7,744,463 1.07%
    New Zealand Permanent Trustees Limited 6,003,926 0.83%
    UBS Nominees Pty Ltd 5,936,820 0.82%
    JBWere (NZ) Nominees Limited 5,815,699 0.80%
    Pt Booster Investments Nominees Limited 5,688,233 0.79%
    HSBC Custody Nominees (Australia) Limited i 5,169,658 0.71%

    Profile

    since

    Note